Odyssey, Permira and Stella Point focus on pharma marketing; Berkshire and Vistria merge post-acute home care tech platforms

View this email online

Odyssey, Permira and Stella Point focus on pharma marketing; Berkshire and Vistria merge post-acute home care tech platforms

Morning Hubsters. John R Fischer here with the US Wire from the New York newsroom.

A product is only as good as its marketing strategy, a universal truth across all industries, including pharma and life sciences. As a result, PE firms such as Odyssey Investment Partners, Permira and Stella Point Capital are pursuing investments in marketing agencies focused on these sectors. I’ve got a listicle of five deals that highlight this trend.

We’ll finish with Friday Focus, where I’ll provide insights on a home care merger between a company backed by Berkshire Partners and one backed by The Vistria Group.I’ll also highlight other recent home care deals PE Hub has covered. Let’s dive in.

Selling to patients

Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of the population, the increased prevalence of chronic disease and the growing complexity and specialization of the treatments themselves. Private equity firms have been snatching up companies that aim to accelerate the commercialization of treatments.

I rounded up five pharma marketing deals from the last five months.

To learn which firms are making deals in the segment, take a look at the premium Wire.

Friday Focus

Forcura, a workflow management company backed by Berkshire Partners, has merged with Medalogix, a software provider backed by The Vistria Group, to form a post-acute technology company focused on home care.

Here are some of the home care deals PE Hub has covered in 2025:

For my insights on the merger and more, check out the full Wire coverage.

That’s it for me. As always, if you have any questions, thoughts or want to chat, please email me at [email protected].

Nina Lindholm will bring you the Europe Wire on Monday, and MK Flynn will be in the US chair.

Cheers,

John

Read the full Wire commentary on PE Hub ...

Also of note (may require subscriptions)

MEAG cools on US renewables: Thomas Bayerl, global head of illiquid assets for the Munich Re investment management arm, bemoans American policy uncertainty, reflecting wider investor wariness. (Infrastructure Investor)

Speaking of MEAG: Gregory Schmitt, the firm's head of private equity and co-investments, discusses what he looks for in a GP and how his team treats co-investment opportunities. His remarks were made in a video interview at PEI Group’s NEXUS 2025 conference last week. (Private Equity International)

With relations between the US and Canada at a low point, Private Equity International senior editor Adam Le asks: could Canadian institutional investors be forced to start rethinking their US private equity exposure or appetite for it?

New Private Markets senior reporter Charles Avery writes that, though a nascent area, systemic investing may hold the key to maximizing the positive impact of private investment.

It’s around five years since countries began to lockdown for the covid-19 pandemic, leading to a dive in the food and hospitality sector. Yet, judging by the string of private equity deals in the restaurant sector, it seems like the industry has more than shaken off the pandemic blues. PE Hub has a roundup of seven restaurant deals worth noting since October.

Nordic Capital, the eighth-largest private equity firm headquartered in Europe, has re-hired an investor relations professional who previously worked at the firm to lead its IR function. Daniel Kanak will join the Jersey-headquartered firm as a partner in mid-May, Private Equity International understands. Kanak joins from Warburg Pincus.

Pantheon has closed on its latest GP-led secondaries program, which is nearly double the size of the firm’s predecessor fund. (Secondaries Investor)

Deals

They said it

“We are thrilled to bring these companies together to help create a leading technology platform that solves real pain points for providers and other stakeholders and ultimately helps to drive better patient care.”

— Sam Spirn, managing director, Berkshire Partners, on the merger of its portco Forcura with The Vistria Group-backed Medalogix.

Today's letter was prepared by John R Fischer

Did someone forward you this email? Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article.

Please visit Buyouts for the latest insight into LP activity and Venture Capital Journal for comprehensive coverage and analysis of what’s happening in VC.

London | New York | Hong Kong | Tokyo | Sydney

PEI Group Ltd is registered in England no.6135779

Registered office: 5th Floor, 100 Wood Street, EC2V 7AN

To update your PE Hub email preferences, or to unsubscribe, click here.